Fluticasone Propionate

Overview

Fluticasone Propionate is a synthetic glucocorticoid with anti-inflammatory and vasoconstrictive properties. It is commonly used in the treatment of respiratory disorders such as asthma and allergic rhinitis.

API suppliers (23)

Suppliers of Fluticasone Propionate evidenced by a US FDA Type II Drug Master File or an EU Certificate of Suitability (CEP). Sources: FDA DMF list, EDQM certification database.

• Cipla USA, Inc.USA3 active DMF
• GlaxoSmithKline plcUnited Kingdom2 active DMF GMP on record
• CORAL DRUGS PVT LTDIndia1 active DMF GMP on record
• NEWCHEM SPAItaly1 active DMF GMP on record
• AARTI PHARMALABS LIMITEDIndia1 active DMF
• INDUSTRIALE CHIMICA SRLItaly1 active DMF GMP on record
• FARMABIOS SPAItaly1 active DMF
• Lupin LimitedIndia1 active DMF GMP on record
• TIANJIN TIANYAO PHARMACEUTICALS CO LTDChina1 active DMF
• SHANDONG SIRUI PHARMACEUTICAL CO LTD1 active DMF
• Apotex Inc.Canada1 active DMF
• CURIA SPAIN SAUSpain1 active DMF GMP on record
• VAMSI LABS LTDIndia1 active DMF GMP on record
• Hubei Gedian Humanwell Pharmaceutical Co. LtdChina1 active DMF GMP on record
• SHANDONG RISEN-SUN PHARMACEUTICAL CO LTD1 active DMF
• WAVELENGTH ENTERPRISES LTDIsrael1 active DMF GMP on record
• STERLING SPAItaly1 active DMF GMP on record
• Aurisco Pharmaceutical Co.,ltdChina1 active DMF GMP on record
• TAPI NL BVNetherlands1 active DMF
• Hovione FarmaCiencia SAPortugal1 active DMF GMP on record
• MYLAN LABORATORIES LTD GMP on record
• SCINOPHARM TAIWAN LTDTaiwan
• Sun Pharmaceutical Industries LimitedIndia GMP on record

Patent & exclusivity (US)

Per the FDA Orange Book (25 approved US products), the latest listed US patent on Fluticasone Propionate expires 23 Feb 2036 and exclusivity 15 Mar 2027. Generic API sourcing typically opens up once these lapse.

Therapeutic areas